Trxade Health Inc
Change company Symbol lookup
Select an option...
MEDS Trxade Health Inc
SUIC Sino United Worldwide Consolidated Ltd
PSRU Valiant Eagle Inc
ON ON Semiconductor Corp
KHC Kraft Heinz Co
SUMO Sumo Logic Inc
TPGY+ TPG Pace Beneficial Finance Corp. *W EXP 10/09/2027
CSTA^ Constellation Acquisition Corp I
HFBL Home Federal Bancorp Inc of Louisiana
FSEA First Seacoast Bancorp
Go

Consumer Discretionary : Internet & Direct Marketing Retail | Small Cap Growth
Company profile

TRxADE Health, Inc., formerly Trxade Group, Inc., is a health services information technology (IT) company. The Company is focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States. The Company operates the TRxADE drug procurement marketplace serving approximately 11,800 members nationwide and offers patient centric telehealth services under the Bonum Health brand. Its products also include DelivMeds mobile application (delivmeds.com); Community Specialty Rx, which is a specialty pharmacy; Integra Pharma Solutions a virtual wholesaler, and MedCheks a health passport application (medcheks.com).

Closing Price
$5.35
Day's Change
-1.32 (-19.79%)
Bid
--
Ask
--
B/A Size
--
Day's High
6.10
Day's Low
5.01
Volume
(Light)
Volume:
4,289,461

10-day average volume:
18,188,662
4,289,461

Company Profile

TRxADE Health, Inc., formerly Trxade Group, Inc., is a health services information technology (IT) company. The Company is focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States. The Company operates the TRxADE drug procurement marketplace serving approximately 11,800 members nationwide and offers patient centric telehealth services under the Bonum Health brand. Its products also include DelivMeds mobile application (delivmeds.com); Community Specialty Rx, which is a specialty pharmacy; Integra Pharma Solutions a virtual wholesaler, and MedCheks a health passport application (medcheks.com).

Valuation Ratios

Price/Earnings (TTM)
--
Price/Sales (TTM)
2.42x
Price/Book (MRQ)
5.28x
Price/Cash Flow (TTM)
--
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend No Regular Dividend is paid
 

Short Interest

May 2021
Current Month
3.8K
Previous Month
3.2K
Percent of Float
0.12%
Days to Cover
0.0992 Days

Share Information

MEDS is in a share class of common stock
Float
3.3M
Shares Outstanding
8.1M
Institutions Holding Shares
16
13.79%

Financial Statements

Balance sheet

Values displayed are in thousands.

Income statement

Values displayed are in thousands.

Cash flow

Values displayed are in thousands.

Company Officers

  • Surendra AjjarapuChmn.
  • Prashant Mark PatelPres.
  • Howard A. DossCFO
  • Ashton MaarabaCorp.Exec.
  • Donald G. Fell

Address

Insider Trading

During the most recent quarter, 20K shares were sold in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.